Menu Close

Vaccine for Alzheimer’s targets tau protein successfully

A new vaccine has prevented the ongoing formation of neurofibrillary tangles in the brain of mice, sparking hopes for a vaccination for Alzheimer’s disease, as well as other types of dementia.

Researchers at the University of Sydney have developed the vaccine, which targets a protein called tau. In addition to Alzheimer’s, tau is involved in front temporal dementia, which afflicts people younger than 65.

Alzheimer’s currently affects more than 35 million people worldwide.

Researchers say their’s is the first study to demonstrate that targeting the protein can be effective once the disease has already set in.

Read more at University of Sydney

Want to write?

Write an article and join a growing community of more than 184,200 academics and researchers from 4,969 institutions.

Register now